Merck & Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Merck & Co using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | AM | MRK | Q1 | $1.40 | $1.87 | $2.07 | 10.70% | $14.49B | $15.20B | $15.78B | 3.78% | Get Alert |
02/01/2024 | AM | MRK | Q4 | $1.62 | -$0.11 | $0.03 | 127.27% | $13.83B | $14.50B | $14.63B | 0.91% | Get Alert |
10/26/2023 | AM | MRK | Q3 | $1.85 | $1.95 | $2.13 | 9.23% | $14.96B | $15.32B | $15.96B | 4.19% | Get Alert |
08/01/2023 | AM | MRK | Q2 | $1.87 | -$2.17 | -$2.06 | 5.07% | $14.59B | $14.39B | $15.04B | 4.50% | Get Alert |
04/27/2023 | AM | MRK | Q1 | $2.14 | $1.32 | $1.40 | 6.06% | $15.90B | $13.78B | $14.49B | 5.13% | Get Alert |
02/02/2023 | AM | MRK | Q4 | $1.80 | $1.54 | $1.62 | 5.19% | $13.52B | $13.67B | $13.83B | 1.17% | Get Alert |
10/27/2022 | AM | MRK | Q3 | $1.78 | $1.75 | $1.85 | 5.71% | $13.15B | $14.07B | $14.96B | 6.32% | Get Alert |
07/28/2022 | AM | MRK | Q2 | $1.31 | $1.69 | $1.87 | 10.65% | $11.40B | $13.87B | $14.59B | 5.21% | Get Alert |
04/28/2022 | AM | MRK | Q1 | $1.40 | $1.83 | $2.14 | 16.94% | $12.08B | $14.68B | $15.90B | 8.32% | Get Alert |
02/03/2022 | AM | MRK | Q4 | $1.32 | $1.53 | $1.80 | 17.65% | $12.51B | $13.16B | $13.52B | 2.74% | Get Alert |
10/28/2021 | AM | MRK | Q3 | $1.74 | $1.55 | $1.75 | 12.90% | $12.55B | $12.33B | $13.15B | 6.68% | Get Alert |
07/29/2021 | AM | MRK | Q2 | $1.37 | $1.44 | $1.31 | -9.03% | $10.87B | $11.54B | $11.40B | -1.20% | Get Alert |
04/29/2021 | AM | MRK | Q1 | $1.50 | $1.63 | $1.40 | -14.11% | $12.06B | $12.66B | $12.08B | -4.58% | Get Alert |
02/04/2021 | AM | MRK | Q4 | $1.16 | $1.38 | $1.32 | -4.35% | $11.87B | $12.68B | $12.51B | -1.31% | Get Alert |
10/27/2020 | AM | MRK | Q3 | $1.51 | $1.43 | $1.74 | 21.68% | $12.40B | $12.17B | $12.55B | 3.13% | Get Alert |
07/31/2020 | AM | MRK | Q2 | $1.30 | $1.04 | $1.37 | 31.73% | $11.76B | $10.39B | $10.87B | 4.64% | Get Alert |
04/28/2020 | AM | MRK | Q1 | $1.22 | $1.34 | $1.50 | 11.94% | $10.82B | $11.46B | $12.06B | 5.21% | Get Alert |
02/05/2020 | AM | MRK | Q4 | $1.04 | $1.15 | $1.16 | 0.87% | $11.00B | $11.98B | $11.87B | -0.93% | Get Alert |
10/29/2019 | AM | MRK | Q3 | $1.19 | $1.24 | $1.51 | 21.77% | $10.79B | $11.63B | $12.40B | 6.60% | Get Alert |
Merck & Co (MRK) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on April 25, 2024 for Q1.
Merck & Co (MRK) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on April 25, 2024 for Q1 and the Actual EPS was $2.07, which beat the estimate of $1.87.
Merck & Co (MRK) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on April 25, 2024 for Q1 and the Actual Revenue was $15.8B, which beat the estimate of $15.2B.
Browse earnings estimates, EPS, and revenue on all stocks.